MARION — Elgin's boys wrestling team showcased its depth in winning its own Elgin Pool Tournament on Saturday. The Comets ...

The Ebola virus devastated west Africa in 2014, claiming over 11,000 lives in Sierra Leone, Liberia and Guinea.

Gilead Sciences Inc. closed $6.85 short of its 52-week high ($98.90), which the company achieved on November 11th.

Brubaker opened the second quarter with a basket, but Cameron Vickers scored four straight for the Indians to make it a 20-18 ...

Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest master-planned ...

Padlock Therapeutics investors accused Bristol Myers of avoiding making milestone payments promised under a 2016 deal.

New York, United States - September 05, 2024 Demonstrators protest against Gilead Pharmaceuticals in midtown Manhattan.

Gilead Sciences, Inc. GILD announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the European ...

US private investment firm AE Industrial Partners is acquiring Israeli cyberattack company Paragon Solutions, sources close ...

● Marion Harding wrestler Sidney Barkley won her weight class at Urbana's Battle of the Hill Tournament. ● Cardington ...

Gilead Sciences, Inc. (GILD) stock saw a decline, ending the day at $91.86 which represents a decrease of $-0.52 or -0.56% from the prior close of $92.38. The stock opened at $91.66 and touched a low ...

Gilead (GILD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.